Skip to content
Catalyst

PapersPMID:23804546

Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial.

Obesity (Silver Spring, Md.)2014The record ↗

findings
4
compound
1
endpoints
4
PMID:23804546
  1. Finding, very limited evidencelowersBody mass
  2. Finding, very limited evidencelowersFat mass
  3. Finding, very limited evidencelowersBody fat percentage (percent body fat)
  4. Finding, very limited evidencelowersBody mass index
Study, every finding
RCT · 3 months
Dose studied, every finding
450 mg per day
Population, every finding
Obese Korean adults without any diagnosed disease (BMI of 25 kg/m2 or more and waist-hip ratio of 0.90 or more for men, 0.85 or more for women)

Study record

Design
randomised controlled trial
Species
human
Population
Obese Korean adults (BMI 25 or more and elevated waist-hip ratio) not diagnosed with any disease; actiponin, a heat-processed Gynostemma pentaphyllum extract. Abstract only, no full text
Participants
80
Comparator
placebo
Duration
84 days
Endpoints measured
6